Ranexa 375 mg prolonged-release tablets

Company
A. Menarini Pharmaceuticals Ireland Ltd
Active Ingredient
Dosage Form
Prolonged-release tablet
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/08/462/1 375 milligram(s) C01EB, C01EB18 Prolonged-release tablet
EU/1/08/462/2 375 milligram(s) C01EB, C01EB18 Prolonged-release tablet
EU/1/08/462/7 375 milligram(s) C01EB, C01EB18 Prolonged-release tablet
EU/1/08/462/8 375 milligram(s) C01EB, C01EB18 Prolonged-release tablet
Licence number
EU/1/08/462/1
Strength
375 milligram(s)
ATC Code
C01EB, C01EB18
Dosage Form
Prolonged-release tablet
Licence number
EU/1/08/462/2
Strength
375 milligram(s)
ATC Code
C01EB, C01EB18
Dosage Form
Prolonged-release tablet
Licence number
EU/1/08/462/7
Strength
375 milligram(s)
ATC Code
C01EB, C01EB18
Dosage Form
Prolonged-release tablet
Licence number
EU/1/08/462/8
Strength
375 milligram(s)
ATC Code
C01EB, C01EB18
Dosage Form
Prolonged-release tablet

A. Menarini Pharmaceuticals Ireland Ltd

Castlecourt, Monkstown Farm, Monsktown, Glenageary, Co. Dublin, Ireland

Telephone
+3531800283045
Email
medinfo@menarini.ie